Mounjaro 2.5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F6DBN
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $36,612
Award facts
- Contract value 100% obligated
- $36,611.61 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $36,611.61 by the Defense Logistics Agency (DLA) on December 15, 2025, with an ultimate completion date of December 16, 2025. The delivery order procures Mounjaro 2.5 mg/0.5 mL pen injections (0.5 mL), a diabetes medication, under firm fixed price terms with no set-aside designation. This award represents a competitive procurement executed through the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical.
This delivery order is issued under AmerisourceBergen's prime indefinite delivery/indefinite quantity contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply pharmaceutical products and medical supplies across multiple therapeutic domains to military healthcare systems, the Defense Health Agency, U.S. Coast Guard, and other federal health programs. The contract reflects AmerisourceBergen's established capability to fulfill federal medical procurement requirements through open competition, as evidenced by its portfolio of competitively awarded contracts ranging across diabetes medications, neurological treatments, pain management pharmaceuticals, and specialized medical supplies.
Quick answers
Who was awarded contract SPE2DR26F6DBN?
SPE2DR26F6DBN was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 15, 2025.
How much is contract SPE2DR26F6DBN worth?
The government has obligated $36,612 on SPE2DR26F6DBN.
Is contract SPE2DR26F6DBN an order under another contract?
Yes. SPE2DR26F6DBN is a delivery order under SPE2DR25D2213, an indefinite delivery contract.
Was contract SPE2DR26F6DBN competed?
The extent of competition for SPE2DR26F6DBN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award